Pathogenic mechanisms of glucocorticoid-induced osteoporosis

M Chen, W Fu, H Xu, C Liu - Cytokine & growth factor reviews, 2023 - Elsevier
Glucocorticoid (GC) is one of the most prescribed medicines to treat various inflammatory
and autoimmune diseases. However, high doses and long-term use of GCs lead to multiple …

The role of miR‐29 family in disease

M Horita, C Farquharson… - Journal of cellular …, 2021 - Wiley Online Library
MicroRNAs are small noncoding RNAs that can bind to the target sites in the 3'‐untranslated
region of messenger RNA to regulate posttranscriptional gene expression. Increasing …

BMSC-derived exosomal miR-29a promotes angiogenesis and osteogenesis

G Lu, P Cheng, T Liu, Z Wang - Frontiers in cell and developmental …, 2020 - frontiersin.org
Angiogenesis and osteogenesis are tightly coupled during bone modeling and remodeling
processes. Here we reported that bone marrow mesenchymal stem cell (BMSC)-derived …

The emerging role of microRNAs in NAFLD: highlight of microRNA-29a in modulating oxidative stress, inflammation, and beyond

HY Lin, YL Yang, PW Wang, FS Wang, YH Huang - Cells, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and
ranges from steatosis to steatohepatitis and to liver fibrosis. Lipotoxicity in hepatocytes …

[HTML][HTML] Contribution of miRNAs and lncRNAs in osteogenesis and related disorders

S Ghafouri-Fard, A Abak, ST Avval, S Rahmani… - Biomedicine & …, 2021 - Elsevier
Non-coding RNAs have been found to regulate several developmental processes among
them is osteogenesis. Although these transcripts have several distinct classes, two classes …

miRNAs in osteoclast biology

MM Weivoda, SK Lee, DG Monroe - Bone, 2021 - Elsevier
MicroRNAs (miRNAs) are a class of short RNA molecules that mediate the regulation of
gene activity through interactions with target mRNAs and subsequent silencing of gene …

Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages

E Sajjadi, G Gaudioso, A Terrasi, F Boggio… - Frontiers in Molecular …, 2022 - frontiersin.org
Background: Breast cancer with osteoclast-like stromal giant cells (OSGC) is an exceedingly
rare morphological pattern of invasive breast carcinoma. The tumor immune …

Micro ribonucleic Acid− 29a (miR− 29a) antagonist normalizes bone metabolism in osteogenesis imperfecta (OI) mice model

JY Ko, FS Wang, SH Chen, SJ Kuo - Biomedicines, 2023 - mdpi.com
Osteogenesis imperfecta (OI) is not curative nowadays. This study tried to unriddle the
therapeutic potential of micro ribonucleic acid-29a (miR-29a) antagonist in treating OI in a …

RANKL impairs the TLR4 pathway by increasing TRAF6 and RANK interaction in macrophages

RF Mota, PH Cavalcanti de Araújo… - BioMed Research …, 2022 - Wiley Online Library
High serum levels of osteoprotegerin (OPG) are found in patients with obesity, type 2
diabetes, sepsis, or septic shock and are associated with a high mortality rate in stroke. The …

Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone …

HC Hrdlicka, RC Pereira, B Shin, SP Yee, AC Deymier… - Bone, 2021 - Elsevier
Abstract miRNAs play a vital role in post-transcriptional regulation of gene expression in
osteoblasts and osteoclasts, and the miR-29 family is expressed in both lineages. Using …